What is acute coronary syndrome (ACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Coronary Syndrome Overview

Acute coronary syndrome (ACS) is a spectrum of acute myocardial ischemic conditions caused primarily by atherosclerotic plaque rupture or erosion with superimposed thrombosis, encompassing three distinct clinical entities: ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). 1, 2

Definition and Classification

ACS represents a continuum of disease severity sharing a common pathophysiological mechanism:

  • STEMI accounts for approximately 30% of ACS cases and reflects acute total coronary occlusion with persistent ST-segment elevation (>20 minutes) on ECG 3, 2, 4

  • NSTEMI represents approximately 70% of ACS cases, involves myocardial necrosis with elevated cardiac biomarkers (troponin above the 99th percentile) but without persistent ST-elevation, indicating partial or intermittent arterial occlusion 1, 2, 4

  • Unstable angina presents with ischemic symptoms and ECG changes but without biomarker elevation indicating myocardial necrosis—though with increasingly sensitive troponin assays, biomarker-negative ACS is becoming rarer 3, 2

Pathophysiology

The underlying mechanism involves a dynamic cascade of events:

  • Plaque disruption occurs through atherosclerotic plaque rupture or erosion, exposing the highly procoagulant lipid core to circulating platelets and coagulation proteins 3, 1

  • Plaques prone to rupture have characteristic features: large lipid core, thin fibrous cap, high macrophage density, and low smooth muscle cell density 3

  • Thrombosis formation with varying degrees of coronary obstruction and distal embolization creates the acute imbalance between myocardial oxygen supply and demand 3

  • The pathophysiology is dynamic—patients can rapidly progress from one clinical condition to another during initial presentation, requiring continuous monitoring 1

Clinical Presentation

Chest discomfort at rest is the cardinal symptom, affecting approximately 79% of men and 74% of women, typically described as substernal pressure, tightness, or burning that may radiate to the left arm, jaw, or back. 2, 4

Atypical presentations are common and include:

  • Isolated dyspnea without chest pain (approximately 40% of men and 48% of women present with nonspecific symptoms) 2, 4
  • Epigastric pain mimicking gastrointestinal pathology 2
  • Syncope or presyncope 2
  • These atypical presentations occur more frequently in elderly patients, diabetics, and women 2

Critical pitfall to avoid:

Chest pain that is reproducible with palpation or varies with breathing or position is less likely to represent ACS, but a normal ECG does not exclude ACS—many patients with NSTE-ACS have either nonspecific changes or a completely normal ECG at presentation 3, 1, 5

Diagnostic Approach

The initial diagnosis must be based on three key elements obtained rapidly:

  1. 12-lead ECG within 10 minutes of presentation to distinguish STEMI from NSTE-ACS 3, 1, 4

    • STEMI: Persistent ST-segment elevation ≥1 mm in two contiguous leads 2
    • NSTE-ACS: ST-segment depression ≥0.5 mm, T-wave inversions, or combined changes (approximately 31% have ST-depression, 12% T-wave inversions, 16% both, and 41% neither) 2, 4
  2. High-sensitivity cardiac troponin (hs-cTn) T or I with at least one value above the 99th percentile distinguishes NSTEMI from unstable angina 1

    • Serial troponin measurements at 6-12 hour intervals are required for patients with initial negative results 2
  3. Clinical history and symptomatology focusing on symptom characteristics, risk factors, and prior cardiac history 1

Risk Stratification

Two critical questions guide management decisions:

  • What is the likelihood that symptoms represent ACS? 3
  • What is the likelihood of adverse clinical outcomes (death, MI, recurrent ischemia)? 3

Common risk factors include age ≥65 years, current smoking, hypertension, diabetes mellitus, hyperlipidemia, BMI >25 kg/m², family history of premature coronary artery disease, and prior abnormal cardiac stress test 5

The median age at ACS presentation in the United States is 68 years (interquartile range 56-79), with a male-to-female ratio of approximately 3:2 3

References

Guideline

Acute Coronary Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Coronary Syndrome: Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.